logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 5
  • 1
    Bhartia, Shyam Sunder
    Born in November 1952
    Individual (3 offsprings)
    Officer
    2019-04-17 ~ 2026-02-05
    OF - Director → CIF 0
  • 2
    Rajpal, Jaidev Sanjeev, Dr
    Born in January 1973
    Individual (1 offspring)
    Officer
    2023-02-21 ~ now
    OF - Director → CIF 0
  • 3
    White, Stephen Barry
    Born in March 1978
    Individual (2 offsprings)
    Officer
    2026-02-24 ~ now
    OF - Director → CIF 0
  • 4
    Yadav, Pramod
    Ceo born in September 1963
    Individual (2 offsprings)
    Officer
    2019-04-17 ~ 2023-02-27
    OF - Director → CIF 0
    Yadav, Pramod
    Individual (2 offsprings)
    Officer
    2019-04-17 ~ 2023-02-28
    OF - Secretary → CIF 0
  • 5
    Krawtschuk, Christopher Stanley
    Cfo Of Jubilant Pharma born in November 1973
    Individual (2 offsprings)
    Officer
    2021-03-03 ~ 2022-10-04
    OF - Director → CIF 0
parent relation
Company in focus

JUBILANT PHARMA UK LIMITED

Period: 2019-04-17 ~ now
Company number: 11952129
Registered name
JUBILANT PHARMA UK LIMITED - now
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
32024-04-01 ~ 2025-03-31
32023-04-01 ~ 2024-03-31
Property, Plant & Equipment
2,528 GBP2025-03-31
1,830 GBP2024-03-31
Fixed Assets
2,528 GBP2025-03-31
1,830 GBP2024-03-31
Total Inventories
3,725,773 GBP2025-03-31
4,360,970 GBP2024-03-31
Debtors
Current
2,242,957 GBP2025-03-31
2,095,196 GBP2024-03-31
Cash at bank and in hand
239,015 GBP2025-03-31
142,839 GBP2024-03-31
Current Assets
6,207,745 GBP2025-03-31
6,599,005 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-5,701,971 GBP2025-03-31
Net Current Assets/Liabilities
505,774 GBP2025-03-31
83,705 GBP2024-03-31
Total Assets Less Current Liabilities
508,302 GBP2025-03-31
85,535 GBP2024-03-31
Net Assets/Liabilities
507,670 GBP2025-03-31
85,535 GBP2024-03-31
Equity
Called up share capital
5,000 GBP2025-03-31
5,000 GBP2024-03-31
5,000 GBP2023-04-01
Retained earnings (accumulated losses)
502,670 GBP2025-03-31
80,535 GBP2024-03-31
-180,860 GBP2023-04-01
Equity
507,670 GBP2025-03-31
85,535 GBP2024-03-31
-175,860 GBP2023-04-01
Profit/Loss
Retained earnings (accumulated losses)
422,135 GBP2024-04-01 ~ 2025-03-31
261,395 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
422,135 GBP2024-04-01 ~ 2025-03-31
261,395 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
422,135 GBP2024-04-01 ~ 2025-03-31
261,395 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
422,135 GBP2024-04-01 ~ 2025-03-31
261,395 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Computers
4,655 GBP2025-03-31
3,100 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Computers
1,270 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
2,127 GBP2025-03-31
Property, Plant & Equipment
Computers
2,528 GBP2025-03-31
1,830 GBP2024-03-31
Finished Goods/Goods for Resale
3,725,773 GBP2025-03-31
4,360,970 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
2,183,702 GBP2025-03-31
2,064,746 GBP2024-03-31
Other Debtors
Current
52,815 GBP2025-03-31
1,558 GBP2024-03-31
Prepayments/Accrued Income
Current
6,440 GBP2025-03-31
5,419 GBP2024-03-31
Debtors - Deferred Tax Asset
Current
23,473 GBP2024-03-31
Cash and Cash Equivalents
239,015 GBP2025-03-31
142,839 GBP2024-03-31
Trade Creditors/Trade Payables
Current
107,567 GBP2025-03-31
146,582 GBP2024-03-31
Amounts owed to group undertakings
Current
4,624,100 GBP2025-03-31
5,964,509 GBP2024-03-31
Corporation Tax Payable
Current
137,062 GBP2025-03-31
Taxation/Social Security Payable
Current
266,338 GBP2025-03-31
246,324 GBP2024-03-31
Other Creditors
Current
57,194 GBP2025-03-31
3,816 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
509,710 GBP2025-03-31
154,069 GBP2024-03-31
Creditors
Current
5,701,971 GBP2025-03-31
6,515,300 GBP2024-03-31
Net Deferred Tax Liability/Asset
-632 GBP2025-03-31
23,473 GBP2024-03-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-24,105 GBP2024-04-01 ~ 2025-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
-632 GBP2025-03-31

  • JUBILANT PHARMA UK LIMITED
    Info
    Registered number 11952129
    Office 14, Bizspace Ashford The Cobalt Building, 1600 Eureka Park, Lower Pemberton Kennington, Ashford TN25 4BF
    PRIVATE LIMITED COMPANY incorporated on 2019-04-17 (7 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-27
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.